DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/h4vsbr/spinal_cord_injury) has announced the addition of Global Markets Direct's new report "Spinal Cord Injury - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Spinal Cord Injury - Pipeline Review, H2 2012', provides an overview of the Spinal Cord Injury therapeutic pipeline. This report provides information on the therapeutic development for Spinal Cord Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinal Cord Injury. 'Spinal Cord Injury - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Spinal Cord Injury.

- A review of the Spinal Cord Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Spinal Cord Injury pipeline on the basis of route of administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

Follow this link:
Research and Markets: Spinal Cord Injury - Pipeline Review, H2 2012

Comments are closed.